RUNX1 and myeloid neoplasm: Although limited, the available literature reported high penetrance of germline CEBPA mutations, leading to almost 100% lifetime risk of developing subsequent AML [6], in contrast to other genes with frequent heritable mutations, such as RUNX1, which confers almost ~35% lifetime risk of myeloid neoplasm.